Ribosomal protein L23a pseudogene 15 (RPL23AP15)

Ribosomal protein L23a pseudogene 15 (RPL23AP15) is one of many processed pseudogenes derived from the functional ribosomal protein L23a gene (RPL23A), a structural component of the cytoplasmic large ribosomal 60S subunit[1][5]. Like other RPL23A pseudogenes, RPL23AP15 is considered non-coding and does not produce a functional protein. There are nearly 100 such pseudogenes associated with RPL23A, widely dispersed in the human genome; their precise roles, if any, are largely uncharacterized[1][2][3]. Some pseudogenes of RPL23A (notably RPL23AP53) have been investigated for possible dysregulation in certain cancers, but there is no evidence or literature regarding any functional role of RPL23AP15 in human disease or drug interaction[2]. Pseudogenes like RPL23AP15 are often studied for their potential to regulate their parent gene via gene expression interference or as genomic markers, but this has not been established for RPL23AP15. Key distinctions and limitations: - RPL23AP15 is a *pseudogene*, not a protein-coding gene, enzyme, transporter, receptor, or recognized therapeutic target[1][3]. - There is no mechanistic, diagnostic, or therapeutic information available for this pseudogene in the scientific literature[1][2][3]. - Information for other pseudogenes in the RPL23A family (e.g., RPL23AP53) should not be generalized to RPL23AP15 unless otherwise demonstrated[2]. Note: The canonical and functional protein relevant for ribosome biology and disease involvement is "60S ribosomal protein L23a" (*RPL23A*), not "RPL23AP15". For molecular drug targeting or disease association, *RPL23A* might be relevant, but "RPL23AP15" is not.

Other names

RPL23A_4_173RPL23A pseudogene 15RPL23AP15